首页> 外国专利> A novel vaccine that targets tumor vessels as an efficient tool in tumor therapy

A novel vaccine that targets tumor vessels as an efficient tool in tumor therapy

机译:一种靶向肿瘤血管的新型疫苗,是肿瘤治疗中的有效工具

摘要

pThe invention relates to a composition for the treatment of various cancers. The composition is a vaccine containing sequences of EDB, EDA, annexin Al, endosialin, C domain of tenascin C or magic roundabout (MR) or fragments thereof as single or in a combination coupled to one or several heterologous foreign carrier molecules. The vaccine will produce antibodies that are directed against self proteins which are preferentially expressed in and around tumor vessels. The vaccine is preferably administrated together with an adjuvant./p
机译:本发明涉及用于治疗各种癌症的组合物。该组合物是一种疫苗,其包含与单个或组合结合至一个或几个异源外来载体分子的EDB,EDA,膜联蛋白A1,内皮唾液酸蛋白,腱生蛋白C或魔环岛(MR)的C结构域或其片段的序列。该疫苗将产生针对自身蛋白质的抗体,这些蛋白质优先在肿瘤血管内和周围表达。疫苗最好与佐剂一起给药。

著录项

  • 公开/公告号IN2012DN05163A

    专利类型

  • 公开/公告日2015-10-23

    原文格式PDF

  • 申请/专利权人 THERAVAC PHARMACEUTICALS AB;

    申请/专利号IN5163/DELNP/2012

  • 发明设计人 HELLMAN LARS;OLSSON ANNA-KARIN;

    申请日2012-06-11

  • 分类号A61K39/00;A61K39/385;

  • 国家 IN

  • 入库时间 2022-08-21 15:15:05

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号